N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

Clinical Trial ID NCT00093353

PubWeight™ 2.08‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00093353

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Systematic identification of pharmacogenomics information from clinical trials. J Biomed Inform 2012 1.03
2 Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma: a new approach to neuroblastoma therapy consortium study. J Clin Oncol 2009 1.03
Next 100